Abstract:Macroautophagy is a major cellular degradation pathway for long-lived proteins and cellular organelles to maintain cellular homeostasis. Reduced autophagy has been implicated in neurodegenerative diseases, metabolic syndrome, and tumorigenesis. In contrast, increased autophagy has been shown to protect against tissue injury and aging. Here we employed a cell-based quantitative high-throughput image screening (qHTS) for autophagy modulators using mouse embryonic fibroblasts (MEFs) that are stably expressing GFP-LC3. The library of pharmacologically active compounds (LOPAC) was used to screen for the autophagy modulators in compounds alone or in combination with the lysosome inhibitor chloroquine (CQ). The GFP-LC3 puncta were then quantified to measure autophagic flux. The primary screening revealed 173 compounds with efficacy more than 40%. These compounds were cherry-picked and re-tested at multiple different concentrations using the same assay. A number of novel autophagy inducers, inhibitors, and modulators with dual-effects on autophagy were identified from the cherry-pick screening. Interestingly, we found a group of compounds that induce autophagy are related to dopamine receptors and are commonly used as clinical psychiatric drugs. Among them, indatraline hydrochloride (IND), a dopamine inhibitor, and chlorpromazine hydrochloride (CPZ) and fluphenazine dihydrochloride (FPZ), two dopamine receptor antagonists, were further evaluated. We found that FPZ-induced autophagy through mTOR inhibition but IND and CPZ induced autophagy in an mTOR-independent manner. Our data suggest that image-based autophagic flux qHTS can efficiently identify autophagy inducers and inhibitors.

Identification of Novel Vacuolin-1 Analogues As Autophagy Inhibitors by Virtual Drug Screening and Chemical Synthesis.

Inhibition of Autophagy by a Small Molecule Through Covalent Modification of the LC3 Protein

Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1

Discovery of Small-Molecule Autophagy Inhibitors by Disrupting the Protein-Protein Interactions Involving Autophagy-Related 5

Small molecule regulators of autophagy identified by an image-based high-throughput screen.

A cell-based quantitative high-throughput image screening identified novel autophagy modulators

Structure-Based Design and Discovery of a Potent and Cell-Active LC3A/B Covalent Inhibitor.

Identification of Anhydrodebromoaplysiatoxin as a Dichotomic Autophagy Inhibitor

Synthesis and screening of 3-MA derivatives for autophagy inhibitors

Autophagy Regulators As Potential Cancer Therapeutic Agents: A Review

Identification and Functional Studies of New Autoph-agy Protein Machinary

Targeting autophagy with small-molecule activators for potential therapeutic purposes

Depletion of 4E-Bp1 and Regulation of Autophagy Lead to Yxm110-Induced Anticancer Effects

A Novel Acridine Derivative, LS-1-10 Inhibits Autophagic Degradation and Triggers Apoptosis in Colon Cancer Cells

Structure-activity relationship study of small-molecule inhibitor of Atg12-Atg3 protein-protein interaction

Identification of a Small Chemical As a Lysosomal Calcium Mobilizer and Characterization of Its Ability to Inhibit Autophagy and Viral Infection

Discovery of human autophagy initiation kinase ULK1 inhibitors by multi-directional in silico screening strategies

Identification of Novel Tyrosinase Inhibitors with Nanomolar Potency Using Virtual Screening Approaches

Discovery of a Small-Molecule Modulator of the Autophagy-Lysosome Pathway That Targets Lamin A/C and LAMP1, Induces Autophagic Flux, and Affects Lysosome Positioning in Neurons

Rational design and appraisal of selective Cdc2-Like kinase 1 (Clk1) inhibitors as novel autophagy inducers for the treatment of acute liver injury (ALI)

The SAR and action mechanisms of autophagy inhibitors that eliminate drug resistance